Campath, Calcineurin inhibitor reduction and Chronic allograft nephropathy: the 3C Study

Principal investigator: 
Richard Haynes
Organisation: 
University of Oxford
Status: 
Active
Summary: 

The 3C study is a randomised trial investigating different immunosuppression strategies in kidney transplantation. It recruited 852 participants between 2010 and 2013 and these participants are now under long-term follow-up through registries to allow the trial to assess the long-term risks and benefits of the different treatments. A key outcome is transplant function, which is assessed from creatinine measurements done routinely as part of transplant care and collected by the UKRR. These data are critical to the long term assessments.

Links / Outputs:

Guidelines

NICE accredited clinical practice guidelines 

Available here

23rd Annual Report

Analyses about the care provided to patients at UK renal centres.

Read the report

UKRR AKI Report

A report on the nationwide collection of AKI warning test scores. 

Read the report